Cyclopropane

Cyclopropane

SCHEMBL15655137

C1CC1.O=C(O)Nc1nc2cccc(-c3ccc(CN4CCC(CO)CC4)cc3)n2n1

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 15/20 0.80
▸ JAK1 P23458 14/20 0.80
▸ JAK3 P52333 4/20 0.61
▸ TYK2 P29597 3/20 0.61
▸ STK10 O94804 1/20 0.61
▸ ABL1 P00519 1/20 0.61
▸ CYP1A2 P05177 1/20 0.61
▸ CSF1R P07333 1/20 0.61
▸ FLT1 P17948 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ FLT4 P35916 1/20 0.61
▸ FLT3 P36888 1/20 0.61
▸ STAT1 P42224 1/20 0.61
▸ IRAK1 P51617 1/20 0.61
▸ MAPK10 P53779 1/20 0.61
▸ KCNH2 Q12809 1/20 0.61
▸ MERTK Q12866 1/20 0.61
▸ AAK1 Q2M2I8 1/20 0.61
▸ Q6ZSR9 Q6ZSR9 1/20 0.61
▸ ADCK1 Q86TW2 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclopropane SCHEMBL15654463 0.90 JAK2 (0.79) JAK2JAK1JAK3TYK2STK10
Cyclopropane SCHEMBL15653691 0.90 JAK2 (0.71) JAK2JAK1JAK3TYK2STK10
Cyclopropane SCHEMBL15654018 0.89 JAK2 (0.78) JAK2JAK1JAK3TYK2STK10
SCHEMBL2237575 0.89 JAK1 (1.00) JAK2JAK1JAK3TYK2STK10
Cyclopropane SCHEMBL15654113 0.87 JAK3 (0.80) JAK2JAK1JAK3TYK2STK10
Cyclopropane SCHEMBL15653757 0.87 JAK2 (0.80) JAK2JAK1JAK3TYK2STK10
Cyclopropane SCHEMBL15653080 0.87 JAK1 (0.67) JAK2JAK1JAK3TYK2STK10
Cyclopropane SCHEMBL15653666 0.87 JAK1 (0.80) JAK2JAK1JAK3TYK2STK10
Cyclopropane SCHEMBL15653730 0.87 JAK1 (0.80) JAK2JAK1JAK3TYK2STK10
Cyclopropane SCHEMBL15654799 0.86 JAK2 (0.81) JAK2JAK1JAK3TYK2STK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2361251-B1 NOVEL COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2014-04-30 — — EP claimed
US-20100291151-A1 1-METHYLPYRAZOLE MODULATORS OF SUBSTANCE P, CALCITONIN GENE-RELATED PEPTIDE, ADRENERGIC RECEPTOR, AND/OR 5-HT RECEPTOR AUSPEX PHARMACEUTICALS, INC. (US) 2010-11-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100291151-A1 1-METHYLPYRAZOLE MODULATORS OF SUBSTANCE P, CALCITONIN GENE-RELATED PEPTIDE, ADRENERGIC RECEPTOR, AND/OR 5-HT RECEPTOR TACR1, HTR3A, HTR3C JAK2 2588/4885JAK1 2767/4885JAK3 2390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback